Canada Pension Plan Investment Board
VIR icon

Canada Pension Plan Investment Board’s Vir Biotechnology VIR Stock Holding History

Canada Pension Plan Investment Board’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Buy
+22,900
New +$218K ﹤0.01% 1556
2026
Q1 		– Sell
-4,400
Closed -$26.5K – 2024
2025
Q4 		$26.5K Buy
+4,400
New +$26.2K ﹤0.01% 1937

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Canada Pension Plan Investment Board's VIR Position: Q2 2026 in Review

Canada Pension Plan Investment Board opened a new position in Vir Biotechnology (VIR) in Q2 2026: 22,900 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #1556 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in VIR as recently as Q4 2025.

Canada Pension Plan Investment Board first reported a position in VIR in Q4 2025 and has held it in 2 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Canada Pension Plan Investment Board held 22,900 shares of Vir Biotechnology worth $233K as of Q2 2026.
  • Vir Biotechnology was a new Canada Pension Plan Investment Board position in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1556 holding.
  • Canada Pension Plan Investment Board first reported a position in Vir Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.